Andrea R Genazzani, WCO IOF-ESCEO 2022: Hormone Replacement Therapy for Bone Loss Prevention Post Menopause (Part 2)

It was a pleasure to talk with Dr. Andrea R Genazzani (International Society of Gynecological Endocrinology and European Society of Gynecology) to find out when, in whom and for how long hormone replacement therapy should be administered for bone loss prevention post-menopause.

‘Hormone Replacement Therapy in post-menopause for bone loss prevention: when, how and for how long‘ was presented at WCO IOF-ESCEO 2022, 24-26 March, 2022

Questions

1. When and in whom should HRT be considered for bone loss prevention? (1:16)
2. How can HRT be administered? (3:45)
3. For how long should HRT be administered? (5:59)

Disclosures: Andrea R Genazzani has nothing to disclose in relation to this video interview.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.

Filmed in coverage of the WCO IOF-ESCEO annual meeting 2022.